Global sports apparel giants Nike has suspended ties with Maria Sharapova after the Russian tennis star failed a drug test at the Australian Open.
"We are saddened and surprised by the news about Maria Sharapova," Kejuan Wilkins, a spokesman for Nike, said on Monday.
"We have decided to suspend our relationship with Maria while the investigation continues. We will continue to monitor the situation."
Sharapova disclosed at a news conference on Monday that she had been taking a drug named Meldonium for over a decade for health reasons.
But the World Anti-Doping Agency (WADA) banned the drug from January 1.
Sharapova, the World No.7, said she didn't notice that the drug was banned by the WADA.
The International Tennis Federation (ITF) said on its website on Monday that the 28-year-old would be provisionally banned from March 12. The usual ban for first-time offenders is two years.
The failed drug test came on January 26 -- after Sharapova lost to Serena Williams in the quarter-finals -- and she was charged with an anti-doping violation on March 2, the governing body additionally said.
The failed drug test could cause the five-time Grand Slam winner a spot at the Rio 2016 Olympics and the $298,000 she won in January at the Australian Open.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
